Alvarez-Martinez, Marisol
Cox, Luke S. http://orcid.org/0000-0002-5477-8622
Pearson, Claire F. http://orcid.org/0000-0001-5816-1657
Branchett, William J.
Chakravarty, Probir
Wu, Xuemei
Slawinski, Hubert http://orcid.org/0000-0002-8996-8477
Al-Dibouni, Alaa
Samelis, Vasileios A. http://orcid.org/0000-0002-8986-7385
Gabryšová, Leona
Priestnall, Simon L. http://orcid.org/0000-0002-6027-1879
Suárez-Bonnet, Alejandro
Mikolajczak, Anna http://orcid.org/0009-0002-0603-6867
Briscoe, James http://orcid.org/0000-0002-1020-5240
Powrie, Fiona http://orcid.org/0000-0003-3312-5929
O’Garra, Anne http://orcid.org/0000-0001-9845-6134
Funding for this research was provided by:
Cancer Research UK (FC001126)
Wellcome Trust (FC001126)
RCUK | Medical Research Council (FC001126)
"la Caixa" Foundation
Article History
Received: 7 February 2022
Accepted: 13 March 2024
First Online: 12 April 2024
Competing interests
: F.P. received grant funding or consultancy fees from Roche, Genentech, GSK, Janssen, Novartis and T Cypher. The other authors declare no competing interests.